D116E (p.Asp116Glu) variant of JPH2 (Junctophilin-2)

D116E (p.Asp116Glu) in JPH2 (Junctophilin-2) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.24 / 1. The record also includes population frequency data and structural context.

D116E (p.Asp116Glu) variant details